Opportunity Information: Apply for CDC RFA DD09 908

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Reducing Risks for an Alcohol Exposed Pregnancy (AEP) in High Risk Women Attending Sexually Transmitted Diseases (STD) Clinics in Urban Settings" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
  • This funding opportunity was created on Apr 9, 2009 and posted on Apr 9, 2009.
  • Applicants must submit their applications by Jun 8, 2009 Letter of Intent Deadline May 11, 2009 Application Deadline June 8, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $275,000.00 in funding.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligible applicants that can apply for this funding opportunity are listed below Eligible applicants are the 65 official public health agencies that are current recipients of project cooperative agreements for Comprehensive STD Prevention Systems. Only one application from each Metropolitan Statistical Area (MSA) and/or Metropolitan Division with a population not less than 2 million may be submitted. The agency determined to be the applicant for the Metropolitan Statistical Area (MSA) and/or Metropolitan Division may apply for funding under the eligibility requirements. Once that agency is determined, no other agency within that Metropolitan Statistical Area (MSA) and/or Metropolitan Division can submit an application. The official public health agencies that are identified as Eligible Applicants must collaborate to determine the most appropriate applicant. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
Apply for CDC RFA DD09 908

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This CDC funding opportunity (RFA CDC-RFA-DD09-908) focuses on preventing alcohol-exposed pregnancies (AEP) among women at high risk who are being seen in urban sexually transmitted disease (STD) clinics. The core idea is to build practical, clinic-level capacity inside public health department STD programs so they can deliver and study an evidence-based approach during the preconception period, when preventing an AEP depends largely on reducing risky alcohol use, improving contraception use, or both. The award mechanism is a cooperative agreement, which typically means CDC expects to be actively involved through technical assistance and collaboration rather than functioning only as a passive funder.

The program’s main objective is to support participating STD programs in implementing and evaluating the Project CHOICES Intervention model within their clinic settings. Project CHOICES is intended to reduce AEP risk by addressing two key drivers at the same time: alcohol consumption patterns that could harm a developing fetus and the likelihood of becoming pregnant without effective contraception. In practical terms, this funding is meant to help clinics integrate a structured intervention into routine STD clinic services for women who are not currently pregnant but could become pregnant, and who are drinking at levels that create AEP risk.

A second major requirement is building a data collection and monitoring system robust enough to track meaningful change over time. Applicants are expected to set up or strengthen systems that can measure changes in patients’ alcohol use, assess whether patients are using effective contraception, and determine whether overall risk for AEP is reduced. The announcement also emphasizes collecting relevant sociodemographic information and other factors associated with AEP risk, suggesting the CDC wanted awardees to understand not only whether outcomes improved, but also for whom and under what circumstances the intervention worked best in busy urban STD clinic environments.

A third deliverable is a written report that documents how the CHOICES intervention was modified or tailored for STD clinic workflow, staffing, patient flow, and local context. This includes describing process measures (how implementation actually occurred, barriers, facilitators, fidelity to the model, recruitment and retention issues) and outcome measures (changes in alcohol use, contraception effectiveness, and overall AEP risk). The report is also expected to capture lessons learned so that other STD programs can replicate or adapt the approach, which signals that the CDC viewed these projects as demonstration and learning sites, not just stand-alone service programs.

Funding for the opportunity was limited and competitive. The CDC anticipated making about five awards with an estimated total funding amount of $1,000,000. Individual awards were expected to fall between $200,000 (floor) and $275,000 (ceiling). There was no cost sharing or matching requirement, reducing the financial burden on awardees and making participation more feasible for public health agencies operating under tight budgets.

Eligibility was narrow and tied to existing CDC-funded STD infrastructure. Only the 65 official public health agencies that were already receiving cooperative agreements for Comprehensive STD Prevention Systems were eligible to apply. The opportunity also restricted submissions so that only one application could come from each Metropolitan Statistical Area (MSA) and/or Metropolitan Division with a population of at least 2 million. In other words, large urban areas had to coordinate internally and choose a single lead applicant, and once that lead agency was identified, no other agency within the same MSA/division could submit a competing application. The announcement also allowed for a Bona Fide Agent arrangement, where an agency designated by a state could apply on the state’s behalf, but this required formal documentation (a letter from the state or local government) to be included with the application.

Key administrative details include the posting date of April 9, 2009, a letter of intent deadline of May 11, 2009, and an application deadline of June 8, 2009, with the opportunity later archived on July 8, 2009. The CFDA number associated with the program was 93.283 (CDC Investigations and Technical Assistance). For applicants who needed help accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management contact line was provided (770-488-2700).

Overall, the opportunity can be read as a targeted public health implementation-and-evaluation initiative: use established STD clinic systems in major urban settings to deploy a proven AEP risk-reduction intervention, measure changes in alcohol and contraception behaviors with a solid monitoring framework, and produce practical guidance on how to make the model work in real-world STD clinic operations.

FAQs: CDC Cooperative Agreement RFA CDC-RFA-DD09-908 (Preventing Alcohol-Exposed Pregnancies in Urban STD Clinics)

What is this CDC funding opportunity about?

This CDC opportunity (RFA CDC-RFA-DD09-908) supports public health department STD programs in large urban areas to prevent alcohol-exposed pregnancies (AEP) among women at high risk who are seen in urban sexually transmitted disease (STD) clinics. The focus is on building practical clinic-level capacity to deliver and study an evidence-based approach during the preconception period.

What is the main goal of the program?

The main objective is to implement and evaluate the Project CHOICES Intervention model within STD clinic settings to reduce the risk of alcohol-exposed pregnancy by addressing risky alcohol use and ineffective or non-use of contraception.

What is Project CHOICES in the context of this grant?

Project CHOICES is an evidence-based intervention model intended to reduce AEP risk by working on two drivers at the same time: alcohol consumption patterns that could harm a developing fetus and the likelihood of becoming pregnant without effective contraception.

Who is the intervention intended to reach?

The intervention is intended for women seen in urban STD clinics who are not currently pregnant, could become pregnant, and are drinking at levels that create risk for an alcohol-exposed pregnancy.

What types of changes is the program trying to produce?

The program aims to reduce AEP risk by supporting changes such as reducing risky alcohol use, improving effective contraception use, or both, among the target clinic population.

What kind of funding mechanism is being used?

The award mechanism is a cooperative agreement, meaning CDC expects to be actively involved through technical assistance and collaboration rather than serving only as a passive funder.

How many awards did CDC anticipate making?

CDC anticipated making about five awards under this opportunity.

What was the estimated total funding amount?

The estimated total funding amount was $1,000,000 across all anticipated awards.

What was the expected funding range per award?

Individual awards were expected to range from $200,000 (floor) to $275,000 (ceiling).

Was cost sharing or matching required?

No. The opportunity stated there was no cost sharing or matching requirement.

Who was eligible to apply?

Eligibility was limited to the 65 official public health agencies that were already receiving CDC cooperative agreements for Comprehensive STD Prevention Systems.

Are there limits on how many applications can be submitted per area?

Yes. Only one application could come from each Metropolitan Statistical Area (MSA) and/or Metropolitan Division with a population of at least 2 million. Large urban areas were expected to coordinate and submit a single application through a lead applicant.

Can multiple agencies within the same large MSA submit separate applications?

No. Once a lead agency was identified for an eligible MSA or Metropolitan Division (population of at least 2 million), no other agency within the same MSA/division could submit a competing application.

What is a Bona Fide Agent arrangement and was it allowed?

A Bona Fide Agent arrangement was allowed. This means an agency designated by a state could apply on the state’s behalf, but the application needed formal documentation, including a letter from the state or local government.

What are the main required activities for awardees?

Based on the announcement summary, awardees were expected to (1) implement and evaluate the Project CHOICES intervention in STD clinic settings, (2) build or strengthen a data collection and monitoring system to track change over time, and (3) produce a written report documenting how the intervention was tailored and what was learned.

What does "implement and evaluate" mean in this opportunity?

It refers to integrating the structured Project CHOICES intervention into routine STD clinic services and measuring whether key outcomes improve in real-world clinic operations.

What data collection or monitoring capabilities were expected?

Applicants were expected to establish or strengthen systems that can measure changes in patients’ alcohol use, assess whether patients are using effective contraception, and determine whether overall AEP risk is reduced over time.

What additional information did CDC emphasize collecting?

The announcement emphasized collecting relevant sociodemographic information and other factors associated with AEP risk to better understand for whom, and under what circumstances, the intervention worked best in busy urban STD clinic environments.

What kind of written report was required?

A written report was required to document how the CHOICES intervention was modified or tailored for the STD clinic context, including workflow, staffing, patient flow, and local conditions.

What types of measures were expected in the report?

The report was expected to include process measures (such as how implementation occurred, barriers and facilitators, fidelity to the model, and recruitment/retention issues) and outcome measures (such as changes in alcohol use, contraception effectiveness, and overall AEP risk).

Why did CDC emphasize lessons learned and documentation?

The emphasis suggests CDC viewed awardees as demonstration and learning sites. The intent was to generate practical guidance that other STD programs could replicate or adapt.

When was the opportunity posted and when were key deadlines?

Key dates were: posting date April 9, 2009; letter of intent deadline May 11, 2009; application deadline June 8, 2009. The opportunity was later archived on July 8, 2009.

What is the CFDA number associated with this opportunity?

The CFDA number associated with the program was 93.283 (CDC Investigations and Technical Assistance).

Who should an applicant contact for help accessing the full announcement?

The CDC Procurement and Grants Office Technical Information Management contact line was provided: 770-488-2700.

What setting is the program designed for?

The program is designed specifically for urban STD clinic environments within public health department STD programs, with an emphasis on integrating the intervention into routine clinic services.

Is this opportunity primarily a service-delivery program or an implementation-and-evaluation initiative?

Based on the description, it is a targeted implementation-and-evaluation initiative: deploy an evidence-based intervention in established STD clinics, measure changes in alcohol and contraception behaviors using a strong monitoring framework, and produce practical guidance for broader replication.

Browse more: Grants for Women

Browse more business programs for Women in Business

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Surveillance of Fetal Alcohol Syndrome (FAS) Utilizing the Infrastructure of Existing Surveillance Programs

Previous opportunity: International Programs to Prevent and Control Micronutrient Malnutrition

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA DD09 908

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA DD09 908) also looked into and applied for these:

Funding Opportunity
Surveillance of Fetal Alcohol Syndrome (FAS) Utilizing the Infrastructure of Existing Surveillance Programs Apply for CDC RFA DD09 910

Funding Number: CDC RFA DD09 910
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $250,000
Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) Apply for PAR 09 153

Funding Number: PAR 09 153
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early Diagnosis Cooperative Agreements Apply for CDC RFA PS09 9133

Funding Number: CDC RFA PS09 9133
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Community Health Projects Related to Brownfield/Land Reuse Apply for CDC RFA TS09 904

Funding Number: CDC RFA TS09 904
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $75,000
Translational Tools for Clinical Studies of CAM Interventions (SBIR R43/R44) Apply for RFA AT 09 004

Funding Number: RFA AT 09 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIOSH Small Research Grant Program (R03) Apply for PAR 09 138

Funding Number: PAR 09 138
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $50,000
NIOSH Exploratory and/or Developmental Grant Program(R21) Apply for PAR 09 139

Funding Number: PAR 09 139
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
Early Hearing Detection and Intervention (EHDI) Tracking, Surveillance and Integration Apply for CDC RFA DD09 903

Funding Number: CDC RFA DD09 903
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
NCMHD Exploratory Centers of Excellence (P20) Apply for RFA MD 09 005

Funding Number: RFA MD 09 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $950,000
Implementation of an Integrated HIV/AIDS Program Electronic Monitoring and Reporting System in the Republic of Rwanda under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9117

Funding Number: CDC RFA PS09 9117
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Prevention Intervention Programs Targeting Youth and Most at Risk Populations (MARPs) in the Republic of Rwanda under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 9115

Funding Number: CDC RFA PS09 9115
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,500,000
Establishment of a Regional Caribbean HIV Monitoring and Evaluation (ME) Training and Technical Assistance Coordination Center under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 996

Funding Number: CDC RFA PS09 996
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $175,000
Increasing the Capacity of the Government of Barbados to Expand Coordinated HIV Prevention and Strategic Information Programs in Barbados under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 995

Funding Number: CDC RFA PS09 995
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $350,000
Provision of Integrated HIV Prevention Interventions, including Voluntary Medical Male Circumcision (VMMC) in Nyanza Province, in the Republic of Kenya, under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS09 992

Funding Number: CDC RFA PS09 992
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $3,500,000
Support the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in the Eastern and Kibera Slums of Nairobi, Coptic Hospital affiliated Sites and Bomu Clinic affiliated Sites in th Apply for CDC RFA PS09 991

Funding Number: CDC RFA PS09 991
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $40,500,000
Technical Assistance to United Nations Children s Fund (UNICEF) to Support the Emergency Plan in the Implementation and Evaluation of HIV/AIDS Prevention, Care, Treatment, and Support Activities for Mothers, Children, and Families under the President Apply for CDC RFA PS09 961

Funding Number: CDC RFA PS09 961
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Microbicide Innovation Program (MIP V) (R21/R33) Apply for RFA AI 09 021

Funding Number: RFA AI 09 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Evidence based Approaches to War Related Injuries and Humanitarian Public Health Apply for CDC RFA EH09 904

Funding Number: CDC RFA EH09 904
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $100,000
RFI Avian and Pandemic Influenza and Zoonotic Disease Program PREDICT Apply for USAID M OAA GH HSR 09 877

Funding Number: USAID M OAA GH HSR 09 877
Agency: Agency for International Development
Category: Health
Funding Amount: $75,000,000
RFI Avian and Pandemic Influenza and Zoonotic Disease Program RESPOND Apply for USAID M OAA GH HSR 09 878

Funding Number: USAID M OAA GH HSR 09 878
Agency: Agency for International Development
Category: Health
Funding Amount: $185,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD09 908", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.